By searching in the U.S. National Library of Medicine in March 2015, surprisingly less than 100 articles titles contain the term 'patient blood management'. Nevertheless, patient blood management has been received much attention worldwide in recent years, resulting in hospital-based or national campaigns to educate physicians and nurses in the three-pillar concept of patient blood management [1] . Like many other medical procedures, patient blood management aims at improving the patients' outcome and safety. By then, everything seems to be business as usual, and obviously one might not imagine that the topic is highly charged both politically and emotionally. All stakeholders in healthcare need to overcome the ongoing controversy about the benefit-risk ratio of blood transfusions.
Patient blood management is defined as evidence-based multidisciplinary approach to preoperatively screen and treat patients for anemia, to minimize intraoperative blood loss by elaborating meticulous surgical techniques, individualized goal-directed coagulation management and cell salvage, and finally to harness the patient's physiological capacity for compensation of low hemoglobin levels prior to application of allogeneic blood transfusions [1, 2] . Compared with initiatives for optimal blood use with their motto 'transfusion of the right unit of blood to the right patient at the right time', it is obvious that patient blood management is a broader concept covering many more issues.
The evidence-based medicine approaches are well accepted by the vast majority of scientists and physicians as it facilitates the individual decision making for diagnosis, investigation, and/or therapy by emphasizing different levels of evidence from well-designed and well-conducted randomized clinical trials, systematic reviews, and meta-analyses. Patient blood management is strictly based on the principles of evidence-based medicine. Therefore, it promotes turning away from purely empirical knowledge and fosters the conduction of further clinical trials with special patient subsets, e.g. patients with septic shock [3] and traumatic brain injury [4] Blood donation establishments and specialists in the field of transfusion medicine should be aware that the paradigm shift to a more restrictive use of allogeneic blood or its strict avoidance, if suitable alternatives are available, is already underway in health research and healthcare nowadays [2] . We do well to strengthen our professional ethics to cure patients or to ameliorate illnesses and injuries to our best knowledge. So, voluntary blood donations and their state-of-the-art use is rather an issue of quality than of quantity.
